After 'nightmare' of pain, woman with MS questions why drug shortages aren't prevented

Melanie Gaunt says the synthetic cannabinoid nabilone was "a godsend." Then the company that makes it ran short, a situation one pharmacist says may be tied to the rising demand for alternatives to opioids.

from CBC | Health News http://ift.tt/2I68hha